106 related articles for article (PubMed ID: 3136776)
1. Modulation of urokinase-type plasminogen activator messenger RNA levels in human synovial fibroblasts by interleukin-1, retinoic acid, and a glucocorticoid.
Vitti G; Hamilton JA
Arthritis Rheum; 1988 Aug; 31(8):1046-51. PubMed ID: 3136776
[TBL] [Abstract][Full Text] [Related]
2. Transforming growth factor beta stimulates urokinase-type plasminogen activator and DNA synthesis, but not prostaglandin E2 production, in human synovial fibroblasts.
Hamilton JA; Piccoli DS; Leizer T; Butler DM; Croatto M; Royston AK
Proc Natl Acad Sci U S A; 1991 Aug; 88(16):7180-4. PubMed ID: 1908092
[TBL] [Abstract][Full Text] [Related]
3. Oncostatin M stimulates urokinase-type plasminogen activator activity in human synovial fibroblasts.
Hamilton JA; Leizer T; Piccoli DS; Royston KM; Butler DM; Croatto M
Biochem Biophys Res Commun; 1991 Oct; 180(2):652-9. PubMed ID: 1953736
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-1beta regulates urokinase plasminogen activator (u-PA), u-PA receptor, soluble u-PA receptor, and plasminogen activator inhibitor-1 messenger ribonucleic acid expression in cultured human endometrial stromal cells.
Chung HW; Wen Y; Ahn JJ; Moon HS; Polan ML
J Clin Endocrinol Metab; 2001 Mar; 86(3):1332-40. PubMed ID: 11238529
[TBL] [Abstract][Full Text] [Related]
5. Modulation of plasminogen activator production by interleukin 1: differential responses of fibroblasts derived from human skin and rheumatoid and non-rheumatoid synovium.
Andrews HJ; Cawston TE; Hazleman BL
Biochim Biophys Acta; 1990 Jan; 1051(1):84-93. PubMed ID: 2297544
[TBL] [Abstract][Full Text] [Related]
6. Diverse morphological responses of normal human synovial fibroblasts to mononuclear leukocyte products: relationship to prostaglandin production and plasminogen activator activities, and comparison with the effects of purified interleukin 1.
Clarris BJ; Leizer T; Fraser JR; Hamilton JA
Rheumatol Int; 1987; 7(1):35-41. PubMed ID: 3495854
[TBL] [Abstract][Full Text] [Related]
7. Human synovial fibroblast plasminogen activator. Modulation of enzyme activity by antiinflammatory steroids.
Hamilton JH; Bootes A; Phillips PE; Slywka J
Arthritis Rheum; 1981 Oct; 24(10):1296-303. PubMed ID: 7197936
[TBL] [Abstract][Full Text] [Related]
8. Induction of urokinase-type plasminogen activator receptor by IL-1 beta.
Hasegawa T; Sorensen L; Dohi M; Rao NV; Hoidal JR; Marshall BC
Am J Respir Cell Mol Biol; 1997 Jun; 16(6):683-92. PubMed ID: 9191470
[TBL] [Abstract][Full Text] [Related]
9. Interleukin 1 stimulation of synovial cell plasminogen activator production.
Mochan E; Uhl J; Newton R
J Rheumatol; 1986 Feb; 13(1):15-9. PubMed ID: 3486284
[TBL] [Abstract][Full Text] [Related]
10. Stimulation of the hyaluronic acid levels of human synovial fibroblasts by recombinant human tumor necrosis factor alpha, tumor necrosis factor beta (lymphotoxin), interleukin-1 alpha, and interleukin-1 beta.
Butler DM; Vitti GF; Leizer T; Hamilton JA
Arthritis Rheum; 1988 Oct; 31(10):1281-9. PubMed ID: 3140820
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional regulation of tissue- and urokinase-type plasminogen activator genes by thrombin in human fetal lung fibroblasts.
Hayakawa Y; Tazawa S; Ishikawa T; Niiya K; Sakuragawa N
Thromb Haemost; 1995 Aug; 74(2):704-10. PubMed ID: 8585010
[TBL] [Abstract][Full Text] [Related]
12. Modulation of mRNA levels for urinary- and tissue-type plasminogen activator and plasminogen activator inhibitors 1 and 2 in human fibroblasts by interleukin 1.
Michel JB; Quertermous T
J Immunol; 1989 Aug; 143(3):890-5. PubMed ID: 2501387
[TBL] [Abstract][Full Text] [Related]
13. Glucocorticoid-modulated gene expression of tissue- and urinary-type plasminogen activator and plasminogen activator inhibitor 1 and 2.
Medcalf RL; Van den Berg E; Schleuning WD
J Cell Biol; 1988 Mar; 106(3):971-8. PubMed ID: 3126194
[TBL] [Abstract][Full Text] [Related]
14. Recombinant human interleukin-1 stimulates human articular cartilage to undergo resorption and human chondrocytes to produce both tissue- and urokinase-type plasminogen activator.
Campbell IK; Piccoli DS; Butler DM; Singleton DK; Hamilton JA
Biochim Biophys Acta; 1988 Nov; 967(2):183-94. PubMed ID: 3142527
[TBL] [Abstract][Full Text] [Related]
15. Independent regulation of plasminogen activator inhibitor 2 and plasminogen activator inhibitor 1 in human synovial fibroblasts.
Hamilton JA; Cheung D; Filonzi EL; Piccoli DS; Wojta J; Gallichio M; McGrath K; Last K
Arthritis Rheum; 1992 Dec; 35(12):1526-34. PubMed ID: 1472130
[TBL] [Abstract][Full Text] [Related]
16. Suppression of urokinase-type plasminogen activator mRNA levels in human fibrosarcoma cells and synovial fibroblasts by anti-inflammatory glucocorticoids.
Medcalf RL; Richards RI; Crawford RJ; Hamilton JA
EMBO J; 1986 Sep; 5(9):2217-22. PubMed ID: 3780677
[TBL] [Abstract][Full Text] [Related]
17. Plasminogen activators in tissue remodeling and invasion: mRNA localization in mouse ovaries and implanting embryos.
Sappino AP; Huarte J; Belin D; Vassalli JD
J Cell Biol; 1989 Nov; 109(5):2471-9. PubMed ID: 2509486
[TBL] [Abstract][Full Text] [Related]
18. Retinoic acid upregulates the plasminogen activator system in human epidermal keratinocytes.
Braungart E; Magdolen V; Degitz K
J Invest Dermatol; 2001 May; 116(5):778-84. PubMed ID: 11348470
[TBL] [Abstract][Full Text] [Related]
19. Stimulation of the plasminogen activator activity of human synovial fibroblasts by retinoids.
Hamilton JA
Arthritis Rheum; 1982 Apr; 25(4):432-40. PubMed ID: 7200364
[TBL] [Abstract][Full Text] [Related]
20. Glucocorticoid modulation of plasminogen activators and of one of their inhibitors in the human mammary carcinoma cell line MDA-MB-231.
Busso N; Belin D; Failly-Crépin C; Vassalli JD
Cancer Res; 1987 Jan; 47(2):364-70. PubMed ID: 3098408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
